Moxifloxacin Hydrochloride

6 trials 4 recruiting JAnti-infectives

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

1 Completed trials

6 Sponsors

5 Countries

Phase II

Phase IV

Phase II: 1 Phase IV: 5

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Brain abscess 1 Implant site infection 1

Sponsors using this IMP

Aalborg University Hospital 1 Assistance Publique Hopitaux De Paris 1 Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca 1 Hvidovre Hospital 1 Leiden University Medical Center 1 Region Midtjylland 1

All trials

6 total

AIR. ANTIBIOTIC THERAPY IN RESPIRATORY TRACT INFECTIONS A controlled randomized, open label, multicenter, non-inferiority trial evaluating a… Pending

2024-516097-30-00 Phase IV 1 country Assistance Publique Hopitaux De Paris
The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting

2025-522088-13-00 Phase IV 1 country Region Midtjylland
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting

2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
The RiCOTTA study: Rifampicin Combination Therapy versus Targeted Antibiotic Monotherapy for Infected Joint Prostheses Caused by Staphylococ… Recruiting

2022-501620-26-00 Phase IV 1 country Leiden University Medical Center
Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) Recruiting

2023-505483-11-00 Phase IV 4 countries Aalborg University Hospital
RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BAS… Ended

2023-509075-17-00 Phase II 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Showing 1–6 of 6 trials

← All drugs A–Z